readmarketresearchReport Information More information from: www.readmarket.com/industry-report/137775-Global-Pharmacogenomics-Technology/Theranostics/Companion-Diagnostics-(CDx)-Market |
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Type, Application, Regions and Companies Forecast 2016-2027
Report Code:RMR137775 Publish Date: 2021-04-05
| Price | Single User PDF: $ 3900 | Enterprise PDF : $7800 |
Description:
The latest study on Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Agilent Technologies
Thermo Fisher Scientific Inc.
Pfizer
GE Healthcare
Foundation Medicine
Leica Biosystems Nussloch GmBH
Qiagen NV
F Hoffman La Roche
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Type Segment:
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Application Segment:
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Regions (Countries):
The Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Report:
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market:
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
What is the expected Market size and growth rate of the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market for the forecast period
Where is the largest and fastest growing market for Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market status and future forecast.
To present the key Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements and acquisitions in the market
Frequently Asked Questions - FAQ:
How big is the opportunity for the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market
Which are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market Which companies are the front runners
What are the major end-use industries of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market
|
Table Of Contents:
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type (2016-2027)
1.4.2 PCR
1.4.3 In-situ Hybridization
1.4.4 Immunohistochemistry
1.4.5 Sequencing
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2027)
1.5.2 Oncology
1.5.3 Neurological Disorders
1.5.4 Cardiovascular Disease
1.5.5 Immunological Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size
2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Growth Trends by Regions
2.2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (2016-2027)
2.2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Manufacturers
3.1.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Manufacturers (2016-2020)
3.1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Manufacturers (2016-2020)
3.1.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Concentration Ratio (CR5 and HHI)
3.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players Head office and Area Served
3.3 Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product/Solution/Service
3.4 Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020)
4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020)
5 United States
5.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
5.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in United States
5.3 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
5.4 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application
6 Europe
6.1 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
6.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Europe
6.3 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
6.4 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application
7 China
7.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
7.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in China
7.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
7.4 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application
8 Japan
8.1 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
8.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Japan
8.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
8.4 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
9.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Southeast Asia
9.3 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
9.4 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application
10 India
10.1 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
10.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in India
10.3 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
10.4 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application
11 Central & South America
11.1 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
11.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Central & South America
11.3 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
11.4 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application
12 International Players Profiles
12.1 Qiagen NV
12.1.1 Qiagen NV Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.1.4 Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.1.5 Qiagen NV Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.2.4 GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.2.5 GE Healthcare Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.3.5 Agilent Technologies Recent Development
12.4 F Hoffman La Roche
12.4.1 F Hoffman La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.4.5 F Hoffman La Roche Recent Development
12.5 Foundation Medicine
12.5.1 Foundation Medicine Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.5.5 Foundation Medicine Recent Development
12.6 Thermo Fisher Scientific Inc.
12.6.1 Thermo Fisher Scientific Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.6.5 Thermo Fisher Scientific Inc. Recent Development
12.7 Leica Biosystems Nussloch GmBH
12.7.1 Leica Biosystems Nussloch GmBH Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.7.5 Leica Biosystems Nussloch GmBH Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.8.4 Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
12.8.5 Pfizer Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
|
TABLES AND FIGURES
List of Tables and Figures
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Market Segments
Table Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Covered
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Type 2016-2027
Figure PCR Figures
Table Key Players of PCR
Figure In-situ Hybridization Figures
Table Key Players of In-situ Hybridization
Figure Immunohistochemistry Figures
Table Key Players of Immunohistochemistry
Figure Sequencing Figures
Table Key Players of Sequencing
Figure Others Figures
Table Key Players of Others
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth by Application 2016-2027 (Million US$)
Figure Oncology Case Studies
Figure Neurological Disorders Case Studies
Figure Cardiovascular Disease Case Studies
Figure Immunological Disorders Case Studies
Figure Others Case Studies
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Report Years Considered
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2027 (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions 2016-2027 (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions 2016-2020 (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2016-2020
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2016-2020
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2019
Table Market Top Trends
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Manufacturers (2016-2020) (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Manufacturers (2016-2020)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Manufacturers in 2020
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product/Solution/Service
Table Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Type (2016-2020)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Type (2016-2020)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application (2016-2020)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Application (2016-2020)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Application in 2020
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$)
Table United States Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table United States Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020)
Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$)
Table Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$)
Table China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$)
Table Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$)
Table India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020)
Figure Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$)
Table Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020)
Table Qiagen NV Company Details
Table Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) (Million US$)
Figure Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table Qiagen NV Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table GE Healthcare Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table Agilent Technologies Recent Development
Table F Hoffman La Roche Company Details
Table F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$)
Figure F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table F Hoffman La Roche Recent Development
Table Foundation Medicine Company Details
Table Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$)
Figure Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table Foundation Medicine Recent Development
Table Thermo Fisher Scientific Inc. Company Details
Table Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$)
Figure Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table Thermo Fisher Scientific Inc. Recent Development
Table Leica Biosystems Nussloch GmBH Company Details
Table Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$)
Figure Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table Leica Biosystems Nussloch GmBH Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$)
Figure Pfizer Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
Table Pfizer Recent Development
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (Million US$) 2021-2027
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions (2021-2027)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions in 2027
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD)
Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product (2021-2027) (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product (2021-2027)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product in 2027
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2021-2027) (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2021-2027)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
|